EU Aproves Diabetes Drug

iVillage Member
Registered: 01-18-2007
EU Aproves Diabetes Drug
Tue, 02-26-2008 - 4:02pm

http://www.medscape.com/viewarticle/570612

EU Approves Novartis's Eucreas Diabetes Drug

ZURICH (Reuters) Feb 25 - The European Union approved Novartis's Eucreas oral treatment for diabetes, the Swiss drugmaker said on Monday, following its approval of Galvus (vildagliptin), one of the two-in-one drug's ingredients.

Eucreas combines vildagliptin, a DPP-4 inhibitor, and metformin.

"The approval comes after Novartis proposed changes to the EU label recommending that liver monitoring should be conducted," Novartis said in a statement.

The European Medicines Agency said in September it had backed Eucreas to treat type-2 diabetes. The Agency's recommendations are normally followed by approval in the 27-nation bloc.

The EU approved Galvus on Feb. 1 after Novartis said the label for the drug should warn for liver problems.

PhotobucketPhotobucketchiblinkyPhotobucketchica 2Photobucket